THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Thanh Bui to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Thanh Bui has written about Radiopharmaceuticals.
Thanh Bui
Connection Strength
0.056
Radiopharmaceuticals
  1. Prognostic value of survival in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors: Value of SUVmax or value of other factor? Clin Ter. 2025 Jan-Feb; 176(1):52-59.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES